Evidence map›Paper›PMID 24671708›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2014

Inhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunction.

Ira J Smith, Guillermo L Godinez, Baljit K Singh, Kelly M McCaughey, Raniel R Alcantara, Tarikere Gururaja, Melissa S Ho, Henry N Nguyen, Annabelle M Friera, Kathy A White and 24 more

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Ventilator-induced diaphragmatic dysfunction: pathophysiology, monitoring and advances in potential treatment and prevention.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  5. Diaphragm Function in Health and Disease.Advances in experimental medicine and biology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Ventilator-induced diaphragm dysfunction in critical illness.Experimental biology and medicine (Maywood, N.J.) · 2018
    Review
  20. Role of gp130 in basal and exercise-trained skeletal muscle mitochondrial quality control.Journal of applied physiology (Bethesda, Md. : 1985) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 2 institutions in 1 country.

Ira J SmithRigel Pharmaceuticals, South San Francisco, California, USA; and.
Guillermo L GodinezRigel Pharmaceuticals, South San Francisco, California, USA; and.
Baljit K SinghRigel Pharmaceuticals, South San Francisco, California, USA; and.
Kelly M McCaugheyRigel Pharmaceuticals, South San Francisco, California, USA; and.
Raniel R AlcantaraRigel Pharmaceuticals, South San Francisco, California, USA; and.
Tarikere GururajaRigel Pharmaceuticals, South San Francisco, California, USA; and.
Melissa S HoRigel Pharmaceuticals, South San Francisco, California, USA; and.
Henry N NguyenRigel Pharmaceuticals, South San Francisco, California, USA; and.
Annabelle M FrieraRigel Pharmaceuticals, South San Francisco, California, USA; and.
Kathy A WhiteRigel Pharmaceuticals, South San Francisco, California, USA; and.
John R McLaughlinRigel Pharmaceuticals, South San Francisco, California, USA; and.
Derek HansenRigel Pharmaceuticals, South San Francisco, California, USA; and.
Jason M RomeroRigel Pharmaceuticals, South San Francisco, California, USA; and.
Kristen A BaltgalvisRigel Pharmaceuticals, South San Francisco, California, USA; and.
Mark D ClaypoolRigel Pharmaceuticals, South San Francisco, California, USA; and.
Wei LiRigel Pharmaceuticals, South San Francisco, California, USA; and.
Wayne LangRigel Pharmaceuticals, South San Francisco, California, USA; and.
George C YamRigel Pharmaceuticals, South San Francisco, California, USA; and.
Marina S GelmanRigel Pharmaceuticals, South San Francisco, California, USA; and.
Rongxian DingRigel Pharmaceuticals, South San Francisco, California, USA; and.
Stephanie L YungRigel Pharmaceuticals, South San Francisco, California, USA; and.
Daniel P CregerRigel Pharmaceuticals, South San Francisco, California, USA; and.
Yan ChenRigel Pharmaceuticals, South San Francisco, California, USA; and.
Rajinder SinghRigel Pharmaceuticals, South San Francisco, California, USA; and.
Ashley J SmuderDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA.
Michael P WiggsDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA.
Oh-Sung KwonDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA.
Kurt J SollanekDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA.
Scott K PowersDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA.
Esteban S MasudaRigel Pharmaceuticals, South San Francisco, California, USA; and.
Vanessa C TaylorRigel Pharmaceuticals, South San Francisco, California, USA; and.
Donald G PayanRigel Pharmaceuticals, South San Francisco, California, USA; and.
Taisei KinoshitaRigel Pharmaceuticals, South San Francisco, California, USA; and.
Todd M KinsellaRigel Pharmaceuticals, South San Francisco, California, USA; and tkinsella@rigel.com.
Sunesis (United States) · USUniversity of Florida · US

Funding

Training In Rehabilitation and Neuromuscular PlasticityT32HD043730 · NICHD · UNIVERSITY OF FLORIDA · PI DAVID D FULLER · 2003 to 2026
$5.3M
NICHD NIH HHS T32 HD043730
6 · The paper itself

Abstract

Controlled mechanical ventilation (CMV) is associated with the development of diaphragm atrophy and contractile dysfunction, and respiratory muscle weakness is thought to contribute significantly to delayed weaning of patients. Therefore, therapeutic strategies for preventing these processes may have clinical benefit. The aim of the current study was to investigate the role of the Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) signaling pathway in CMV-mediated diaphragm wasting and weakness in rats. CMV-induced diaphragm atrophy and contractile dysfunction coincided with marked increases in STAT3 phosphorylation on both tyrosine 705 (Tyr705) and serine 727 (Ser727). STAT3 activation was accompanied by its translocation into mitochondria within diaphragm muscle and mitochondrial dysfunction. Inhibition of JAK signaling during CMV prevented phosphorylation of both target sites on STAT3, eliminated the accumulation of phosphorylated STAT3 within the mitochondria, and reversed the pathologic alterations in mitochondrial function, reduced oxidative stress in the diaphragm, and maintained normal diaphragm contractility. In addition, JAK inhibition during CMV blunted the activation of key proteolytic pathways in the diaphragm, as well as diaphragm atrophy. These findings implicate JAK/STAT3 signaling in the development of diaphragm muscle atrophy and dysfunction during CMV and suggest that the delayed extubation times associated with CMV can be prevented by inhibition of Janus kinase signaling.-Smith, I. J., Godinez, G. L., Singh, B. K., McCaughey, K. M., Alcantara, R. R., Gururaja, T., Ho, M. S., Nguyen, H. N., Friera, A. M., White, K. A., McLaughlin, J. R., Hansen, D., Romero, J. M., Baltgalvis, K. A., Claypool, M. D., Li, W., Lang, W., Yam, G. C., Gelman, M. S., Ding, R., Yung, S. L., Creger, D. P., Chen, Y., Singh, R., Smuder, A. J., Wiggs, M. P., Kwon, O.-S., Sollanek, K. J., Powers, S. K., Masuda, E. S., Taylor, V. C., Payan, D. G., Kinoshita, T., Kinsella, T. M. Inhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunction.

Indexed as

AnimalsDiaphragmInterleukin-6Janus KinasesMaleMitochondriaMuscle WeaknessMuscular AtrophyOxidative StressPhosphorylationProteolysisRatsRats, Sprague-DawleyRespiration, ArtificialSerineSignal TransductionInterleukin-6Janus KinasesSerineSTAT3 Transcription FactorTyrosinemitochondriamuscle wastingoxidative stressSTAT3

Identifiers

PMID24671708
PMCPMC4062832
OpenAlexW2134011082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.